Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · THIRUMALAI CHEMICALS LTD · 29 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
THIRUMALAI CHEMICALS LTD
NSE: TIRUMALCHM · BSE: 500412
Commodities › Chemicals › Chemicals & Petrochemicals › Commodity Chemicals

THIRUMALAI CHEMICALS LTD

StateQ1 FY27 filed
Last close · 28 Oct 2026₹117.75
Market cap₹1.4k cr
TTM P/E · P/B · EV/EBITDA— · 0.91 · 95.9

Makes Phthalic Anhydride, Malic Acid and Fumaric Acid at its Indian operations, and is commissioning Maleic Anhydride and Food Ingredients through a greenfield plant in West Virginia, USA being set up by step-down subsidiary TCL Specialties LLC. Consolidated FY26 revenue was Rs 1,735.52 crore; on a standalone basis revenue dropped 37% to Rs 1,35,973 lakhs, with management attributing the decline to weak global demand, pricing pressure and geopolitical challenges. Materials make up 76.9% of revenue, the dominant input cost, followed by other operating expenses at 18.2%, employee costs at 5.1% and depreciation at 5.1%. The US build-out, alongside Indian capacity, drives a heavy investment cycle, with capex running at 34.5% of revenue in FY26. Indian operations have shifted from furnace oil to piped natural gas. AR · MarketPing reader · 2026-08-02

Revenue streams, as the annual report describes them. Phthalic Anhydride, Malic Acid, Fumaric Acid, Maleic Anhydride, Food Ingredients. Asset-heavy commodity chemicals with high capex intensity and exposure to global pricing cycles

What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.

Exhibit 1: Financial summary, FY22–FY26 (all audited; no estimate years)

₹ crore · consolidatedFY22FY23FY24FY25FY26
Revenue1,9982,1322,0832,0501,736
EBITDA (ex other income)4411865149(43)
margin %22.18.72.42.4(2.5)
Owners' profit28100(46)0
EPS, as reported (₹)27.478.77(3.79)(4.50)(14.91)
ROE % · ROCE %25.9 · 30.37.5 · 10.7(3.4) · 0.3(4.0) · 0.3(10.7) · (3.3)
Debt / equity (x)0.150.371.011.481.34
Cash from operations40254237(66)(131)
Capex(74)(363)(811)(613)(599)
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · THIRUMALAI CHEMICALS LTD · 29 October 2026Page 2 of 3

Exhibit 2: Quarterly performance, last 8 quarters

₹ croreQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue525447523450445416424547
Profit before tax9(50)(11)(64)(44)(55)(38)(39)
Net profit5(42)(14)(60)(33)(47)(28)(44)
EPS (₹)0.48(4.10)(1.37)(5.86)(3.07)(3.92)(2.32)(3.62)
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.

Exhibit 3: Peers — basic industry group, by market cap

CompanyM.cap ₹ crP/EP/BEV/EBITDAROE %ROCE %Rev CAGR 5y %EBITDA m. %
TATA CHEMICALS LTD15,351—0.69139.2(7.7)(5.0)7.414.4
DEEPAK FERTILIZERS & PETR14,67914.91.9711.19.98.414.626.1
GUJ NAR VAL FER & CHEM L7,5297.30.835.48.910.38.722.1
TANFAC INDUSTRIES LTD.6,92356.618.55—18.824.3—16.0
GUJARAT ALKALIES & CHEM4,10561.80.798.7(0.0)0.712.418.4
GHCL LIMITED3,5657.81.004.713.316.61.123.9
GRAUER & WEIL IND LTD3,54321.63.2814.415.219.214.520.4
J.G.CHEMICALS LIMITED2,17929.04.0322.212.716.9—11.5
Source: exchange data and filed statements via the screener; multiples at current prices.

Exhibit 4: Where the company sits in its group

MetricCompanyGroup medianRankBetter than
P/B0.91.424 of 6061%
ROCE(5.9)6.058 of 627%
ROE(10.7)5.054 of 6010%
Debt / Equity1.30.252 of 6014%
EBITDA margin6.613.341 of 5830%
Revenue growth21.56.715 of 5474%
Profit growth27.221.031 of 6452%
Market cap14209810 of 6686%
Source: MarketPing peer ranks; a rank is a measurement, not a view.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · THIRUMALAI CHEMICALS LTD · 29 October 2026Page 3 of 3

Exhibit 5: Filings of the last 90 days, with the measured price reaction

Date · filingCategoryImportanceNext day %5-day %
27 Oct 2026 · Promoter group members seek reclassification as public shareholdersownership changesmedium——
22 Oct 2026 · Customs authority seeks Rs. 24.52 lakh over export benefitsregulatory legalmedium——
15 Oct 2026 · Quarterly dematerialisation confirmation certificate filed with exchangescomplianceminimal——
1 Oct 2026 · Thirumalai Chemicals gets Rs 17.31 crore GST show cause notice for FY24regulatory legalhigh——
30 Sept 2026 · GST show cause notice on FY22-23 assessment, demand around Rs 13.52 lakhsregulatory legalhigh——
30 Sept 2026 · Thirumalai Chemicals corrigendum to Sept 30 fund raising intimationfund raisingmedium——
30 Sept 2026 · Thirumalai Chemicals to sell up to 9.5L shares of Ultramarine and Pigmentsfund raisinghigh——
28 Sept 2026 · Trading window closed from Oct 1, 2026 for Q2 resultscomplianceminimal——
30 Aug 2026 · Thirumalai Chemicals to sell up to 5 percent stake in Ultramarine Pigmentsfund raisingmedium——
29 Aug 2026 · Auditor Resigns at TCL Intermediates Material Subsidiarymanagement changesmedium——
Source: exchange announcements; each reaction is measured from the close before the filing. Next day = the close one session after the reaction day (the first session that could trade the filing).

How to read this document

Where a broker report showsThis document showsWhy
A rating (BUY / ADD / REDUCE / SELL)A state: the latest filed quarter and the measured reactionsan event is a fact; a rating is an opinion that requires SEBI RA registration
A target price and upsideThe current price and the multiples against the groupa target is a forecast; a multiple is a measurement
Estimate years marked EMore audited years; no estimatesMarketPing publishes no forecasts — your own model lives on the Models page

Sources, method and disclosures

This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.

Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in